WACKER Q2 2026 results — PACE savings and pension effect boost earnings
- Group sales in Q2 2026 were €1.52 billion, up 7% year‑on‑year.
- EBITDA was €211 million, including €36.7 million pension‑related non‑operating income; operational EBITDA was €175 million.
- Net income for the quarter was €350 million and net cash flow was €243 million, supported by €185.4 million from the sale of Siltronic shares.
- Full‑year sales growth forecast cut to mid‑single‑digit; EBITDA guidance raised to €625–750 million and net financial debt now expected at about €500 million.
Key figures
Group sales in Q2 2026 were €1.52 billion, 7% above Q2 2025 and 8% up on Q1 2026. Reported EBITDA was €211 million, yielding a 13.9% margin; EBIT was €96 million and net income €350 million. Earnings per share amounted to €6.86.
PACE and special effects
EBITDA benefited from savings under the PACE cost‑savings and efficiency program launched in October 2025 and included €36.7 million of non‑operating income from a revaluation of pension provisions after the introduction of a lump‑sum option in Germany. WACKER reports operational EBITDA of €175 million excluding that pension effect.
Regional and divisional performance
About 83% of sales were generated outside Germany. All divisions posted higher sales year‑on‑year: Silicones €757m, Polymers €406m, Biosolutions €99m and Polysilicon €226m. EBITDA rose in Silicones, Polymers and Biosolutions but fell in Polysilicon due to weaker solar‑grade demand and higher energy costs.
Capital, cash, workforce and guidance
Capex in Q2 was €59 million. Net cash flow was €243 million, aided by €185.4 million from Siltronic share proceeds; €243 million of Siltronic‑related effects are reflected in net income. Headcount stood at 16,084. WACKER trimmed full‑year sales growth to mid‑single‑digit, now expects EBITDA of €625–750 million, capex about €300 million, and net financial debt around €500 million.
Source: WACKER
